ANAB – anaptysbio, inc. (US:NASDAQ)

News

Is AnaptysBio (ANAB) Still Attractively Priced After 242% One-Year Share Price Surge? [Yahoo! Finance]
Anaptys Announces Participation at Upcoming Investor Conferences
AnaptysBio (NASDAQ:ANAB) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
AnaptysBio (NASDAQ:ANAB) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
What Investors Should Know About a $163K AnaptysBio Insider Sale [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com